Rajeev M. Shah, 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 302 shares at $7.99 ($2K) on 2022-06-21, disclosed to the SEC on 2022-06-23.
Open-market purchase of $2k ANTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |